Filing Details
- Accession Number:
- 0001104659-22-035345
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-18 08:31:25
- Reporting Period:
- 2022-03-16
- Accepted Time:
- 2022-03-18 08:31:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1633070 | Axcella Health Inc. | AXLA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1774662 | William Hinshaw | C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-16 | 13,089 | $1.91 | 48,012 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the common stock of Axcella Health Inc. acquired by the reporting person in a registered direct offering on March 16, 2022, at a price of $1.91 per share.
Billionaire Hedge Funds
